Biopharmaceutical manufacturer Bavarian Nordic announced on May 13th that significant progress was achieved in demonstrating two versions of its smallpox vaccine, Imvamune, offer satisfactory protection...
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.